SEC Form 4 · accession 0001185185-17-001997
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cherin
Officer — CFO, Treasurer and PAO
Period of report
Sep 1, 2017
Accepted (ET)
Sep 14, 2017 · 3:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2017 | D | 1,000 | $0.32 | D | 330,000 | D | |
| Common Stock | Sep 5, 2017 | D | 1,000 | $0.31 | D | 329,000 | D | |
| Common Stock | Sep 7, 2017 | D | 1,000 | $0.31 | D | 328,000 | D | |
| Common Stock | Sep 11, 2017 | D | 1,000 | $0.32 | D | 327,000 | D | |
| Common Stock | Sep 13, 2017 | D | 2,000 | $0.33 | D | 325,000 | D |
Table II — derivative securities
No Table II lines on this filing.